Reviva Pharmaceuticals reduces stockholder meeting quorum to 33⅓% of voting power

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Board adopted quorum reduction from majority to one-third (33⅓%) of outstanding voting stock.
Amendment effective September 26, 2025; applies to all stockholder meetings unless law or charter requires higher.
Previous Bylaws required a majority of shares entitled to vote in person or by proxy.
No other changes to the Bylaws were made.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

REVIVA PHARMACEUTICALS HOLDINGS, INC.: Reduced quorum requirement for stockholder meetings from majority of voting power to one-third of voting power (effective 2025-09-26).

Change: bylaw amendment
Effective: 2025-09-26

Exact text from the filing

The Amendment reduces the quorum at all meetings of the Company’s stockholders for the transaction of business, except as otherwise required by law or by the Company’s Amended and Restated Certificate of Incorporation, as amended, or Bylaws, to one-third (331⁄3%) of the voting power of the stock outstanding and entitled to vote at the meeting, present in person, present by remote communication, if applicable, or represented by proxy.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

REVIVA PHARMACEUTICALS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-029951

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.